Chemoinformaics analysis of (1S,8R)-7-METHYL-4-PROPAN-2-YLTRICYCLO[6.2.1.02,6]UNDEC-6-ENE
| Molecular Weight | 204.357 | nRot | 1 |
| Heavy Atom Molecular Weight | 180.165 | nRig | 47 |
| Exact Molecular Weight | 204.188 | nRing | 3 |
| Solubility: LogS | -5.157 | nHRing | 0 |
| Solubility: LogP | 6.272 | No. of Aliphatic Rings | 3 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 3 |
| Atoms Count | 39 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 15 | No. of Aromatic Carbocycles | 0 |
| nHetero | 0 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 2 | No. Saturated Carbocycles | 2 |
| No. of Hydrogen atom | 24 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 15 | No. of Saturated Rings | 2 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 0 | No. of Arom Bond | 0 |
| nHA | 0 | APOL | 41.053 |
| nHD | 0 | BPOL | 24.077 |
| QED | 0.181 |
| Synth | 6.526 |
| Natural Product Likeliness | 1.671 |
| NR-PPAR-gamma | 0.01 |
| Lipinski | Rejected |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 1 |
| Pgp-sub | 0.88 |
| HIA | 0.01 |
| CACO-2 | -5.44 |
| MDCK | 0.000012 |
| BBB | 0.77 |
| PPB | 0.960446 |
| VDSS | 1.93 |
| FU | 0.0468649 |
| CYP1A2-inh | 0.021 |
| CYP1A2-sub | 0.973 |
| CYP2c19-inh | 0.214 |
| CYP2c19-sub | 0.972 |
| CYP2c9-inh | 0.087 |
| CYP2c9-sub | 0.861 |
| CYP2d6-inh | 0.904 |
| CYP2d6-sub | 0.926 |
| CYP3a4-inh | 0.889 |
| CYP3a4-sub | 0.946 |
| CL | 6.763 |
| T12 | 0.014 |
| hERG | 0.527 |
| Ames | 0.048 |
| ROA | 0.991 |
| SkinSen | 0.009 |
| Carcinogencity | 0.126 |
| EI | 0.004 |
| Respiratory | 0.973 |
| NR-Aromatase | 0.308 |
| Antiviral | Yes |
| Prediction | 0.932264 |